Stanton Chase
Life Sciences Leadership Conversations: Sebastian Kracht on Patient-Centric Innovation and the Leaders It Needs

Life Sciences Leadership Conversations: Sebastian Kracht on Patient-Centric Innovation and the Leaders It Needs

November 2026

Share:

Video cover
Summary:

In the first of four interviews, Dietrich Hauffe, Global Sector Leader for Life Sciences and Healthcare at Stanton Chase, talks to Sebastian Kracht, who most recently served as Senior Director Global Customer Experience at Abbott Diabetes Care, about the move from product-first to patient-first healthcare. Sebastian recalls a product withdrawal at Bausch + Lomb that forced his team to completely rebuild its offer around customers’ and patients’ needs. He argues that a patient-first company needs empathy toward patients and customers as well as empathy between its own departments, and he describes the qualities boards should test for when they appoint a leader to build a patient-first culture.

A product recall early in Sebastian Kracht’s time at Bausch + Lomb taught him that patient-first leadership begins with empathy. 

About this interview

Dietrich Hauffe, Global Sector Leader for Life Sciences and Healthcare at Stanton Chase, sat down with healthcare marketing executive Sebastian Kracht for a four-part interview series. In part one, they discuss what it takes to put patients first.

Medtech companies discuss customer experience widely, yet few have built their operations around it. A McKinsey analysis of top medtechs found that 78% of the top 50 companies now reference customer experience in investor communications, while fewer than one in five have made it a formal operating priority. 

Customer experience in medtech

Customer experience is in the investor story but rarely in the operating model

78%

of the top 50 medtechs substantively reference customer experience in investor-facing communications

Fewer than1 in 5

have embedded it as a formal operating priority

3

companies publicly disclose a customer satisfaction metric to investors

Source: McKinsey & Company, Why medtechs can’t afford to overlook customer experience, October 2026

Sebastian has spent years putting customers at the center of how companies run. He has held senior marketing and commercial roles at Johnson & Johnson and Bausch + Lomb, and more recently at Abbott Diabetes Care as Senior Director Global Customer Experience. He traces his belief in patient-first leadership to a crisis at Bausch + Lomb. 

What Can a Product Recall Teach a Leader About Putting Patients First?

“Probably no period was as eye-opening as my early days at Bausch + Lomb,” Sebastian says. A couple of weeks after he joined, around 80% of his portfolio had to be pulled from the shelves. “It was heavy, and patients and customers were impacted alike.” 

The company had no new product to fall back on. “The only way back was the reintroduction of previously existing product, relaunched into a market, and an overall category, in turmoil,” he says. Patients had to learn and adopt a new usage regime while customers dealt with a badly disrupted supply chain. Sebastian credits the recovery to service. “This wouldn’t have been possible without a significant upping of the service element in our offering.” 

For Sebastian, service in that period meant showing up. “Customers and consumers want us to show up,” he says. “In a crisis, it can be tempting for a company to go quiet for months while it works things out internally. Being there, and working through it together with patients and customers, makes a big difference.”

Bausch + Lomb recall

How service led the way back

Around 80% of Sebastian’s portfolio was pulled from the shelves weeks into his new job. The recovery was built on “showing up,” being there and being of service.

01
Stay close to patientsSupport them through a new set of offerings and a new usage regime.
02
Help customers across the categoryKeep interruptions low and win back goodwill.
03
Give the supply chain room to recoverRestore continuity after a badly disrupted period.

That service went to patients and customers alike. “We used our customers’ insights to build a new set of offerings, and we worked with our patients, hand-holding them as we reintroduced these offerings into the marketplace,” he says. With customers, the team worked to keep interruptions to a minimum and to win back goodwill while supply returned to normal. 

Winning back market share was part of the goal, but Sebastian is clear that patients came first. “Everything we did during that period was a result of putting our patients first and walking in their footsteps,” he says. “This was about walking with them and supporting them along the way.” 

“Everything we did during that period was a result of putting our patients first and walking in their footsteps.”

Sebastian Kracht

Sebastian Kracht

Why Do Patient-First Companies Need Empathy Inside and Out?

The recall left Sebastian convinced that a patient-first company runs on empathy. “It is all about empathy, I believe,” he says. In his view, that empathy has to face outward toward patients and customers as well as inward toward colleagues. 

Outward empathy starts with looking at the whole marketplace differently. “You identify all the stakeholders involved in a successful user experience, even those you may initially consider remote from the core of what you are doing,” he says. “We sometimes refer to that as the community.” His teams map the connections inside that community and use them to make customers’ and patients’ lives easier. 

Companies often believe they are further along than their customers do. A Deloitte survey of pharma engagement found that 82% of life sciences executives were satisfied with their customer engagement strategies, while only 28% of healthcare professionals (HCPs) felt those strategies met their needs. 

Interactive

Customer engagement in pharma

Executives and HCPs see engagement differently

Switch views to see the same strategies from the HCP side.

82%28%
of life sciences executives are satisfied with their customer engagement strategiesof HCPs feel those strategies meet their needs
0%50%100%

The shaded stretch is where executives rate their strategies higher than the HCPs they are built for.

Source: Deloitte, Unlocking the Future of Customer Engagement in Pharma, over 190 HCPs and 50 pharma executives, March 2025

Inward empathy is about colleagues in other functions and divisions. “If they work in sync, they can deliver outstanding results and beat expectations,” Sebastian says. “Working in silos, they can find or even create hurdles that slow down your project and put its success at risk.” McKinsey’s research on medtech describes companies that have become siloed over decades, where aligning functions often takes months or even years. 

Interactive

Patient-first leadership

Empathy has to run two ways

Switch between outward and inward empathy.

Their loved ones
Healthcare professionals
Key opinion leaders
The
patient
Advisory boards
Patient associations
Governments and advocacy groups

“You identify all the stakeholders involved in a successful user experience, even those you may initially consider remote from the core of what you are doing. We sometimes refer to that as the community.”

Marketing
Sales
Medical
Customer service
Supply chain
Digital
The patient

“Working in silos, they can find or even create hurdles that slow down your project and put its success at risk.”

McKinsey & Company: “It often takes months or even years for medtech companies to align these diverse functions.”

“If they work in sync, they can deliver outstanding results and beat expectations.”

Quotes: Sebastian Kracht. McKinsey & Company, The transformation imperative: Igniting value creation in medtech, February 2025

What Should Boards Look for in a Patient-First Leader?

Empathy also runs through his advice to boards hiring a patient-first leader. The first quality he would test is insight from data. “Data nowadays is everywhere,” he says. “Yet I would argue a lot of it is wasted. I don’t mean big brother data. I mean simple usage, reactions to the communications we send, and satisfaction or dissatisfaction with something helpful we think we did.” 

What boards should test for

Three qualities of a patient-first leader

01

Insight from dataAct on simple usage data and on how people react to what you send them.

02

Connecting the dotsChallenge legacy KPIs and ask which data points reflect patient behavior.

03

EmpathyChoose where along the patient journey you want to make a difference.

BCG’s research supports his point. In BCG’s omnichannel research among more than 100 biopharma and medtech leaders, fewer than half of companies were satisfied with the richness, quality, or timeliness of their data. Patient analytics were among the datasets left underused. Even when next-best-experience engines turn data into recommendations for commercial teams, about 90% of respondents follow those recommendations less than 60% of the time. 

Data in biopharma and medtech

The data is there, but much of it goes underused

Fewer than half

of companies are satisfied with the richness, quality, or timeliness of their data

About 90%

of respondents follow next-best-experience recommendations less than 60% of the time

Source: BCG, How Biopharma and Medtech Leaders Can Get Omnichannel Right, more than 100 senior omnichannel leaders, June 2025

“The data is there,” Sebastian says. “It is what we do with it, and how we act on the insights, that makes the difference to the end-user.” 

The second quality is connecting the dots, which starts with questioning familiar measures. “Sometimes it can be tempting to stick to the one set of data points that has always been tracked, our proverbial KPIs,” he says. “Too often we are told what the KPI should be by a standardized template we have been using for years.” Customer-first and patient-first leaders widen the data they look at and ask which points reflect how patients behave. “To be a little provocative, the data points count for less than the behavior behind them and the levers that change it.” 

“To be a little provocative, the data points count for less than the behavior behind them and the levers that change it.”

Sebastian Kracht

Sebastian Kracht

Medtech reporting has room to improve here, since only three of the top 50 medtechs report a customer satisfaction metric to investors. 

The third quality, empathy, makes the first two useful. “Add the magic ingredient, empathy, and a plethora of new opportunities opens up to you and your teams,” he says. With it, teams can consider “what and where you want to impact along the patient or customer journey,” including whether patients can find the help on offer. Pharma’s patient support programs show what happens when they cannot. According to CoverMyMeds research, only 3% of patients use the support programs that pharmaceutical companies offer, and 59% have little to no knowledge of them. 

Interactive

Patient support programs

Help that few patients reach

Step through 100 patients.

100

patients who could benefit from the support programs pharmaceutical companies offer

59%

have little to no knowledge of those programs

3%

use the support programs on offer

Source: CoverMyMeds, Patient Support Programs: Bridging the Awareness Gap, May 2025

What Does This Mean for Boards Hiring Healthcare Leaders?

Getting customer experience out of investor presentations and into operating models will take leaders with these qualities. A good launch record is only part of what boards should look for. They can also ask how a candidate behaves when the usual KPIs stop explaining the market, and how well that person brings other functions along. Our Life Sciences and Healthcare practice helps boards answer those questions through retained search and leadership advisory. The second article turns to digital and data transformation. 

About the Author

Dietrich Hauffe, Ph.D., is a Partner in Stanton Chase’s Düsseldorf office. He is the firm’s Global Sector Leader for Life Sciences and Healthcare and Global Subsector Leader for Biotechnology, and he also specializes in marketing and sales, R&D, operations, and other appointments. His expertise covers analytical technology, biotechnology, biopharmaceuticals, diagnostics, medical devices, and bioinformatics, and he worked in North America for more than a decade. 

Life Sciences and Healthcare
Leadership Development

How Can We Help?

At Stanton Chase, we're more than just an executive search and leadership consulting firm. We're your partner in leadership.

Our approach is different. We believe in customized and personal executive search, executive assessment, board services, succession planning, and leadership onboarding support.

We believe in your potential to achieve greatness and we'll do everything we can to help you get there.

View All Services